Cannaus
  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Cannaus

NimbinCann bringing ‘seed to shelf’ medical cannabis directly to Australian patients

4 years ago
in National
3
NimbinCann Logo Large

NimbinCann Logo Large

Share on FacebookShare on Twitter

Nimbin – Australia’s cannabis capital, home of the HEMP Party, an icon in the country’s cultural history, venue of the annual MardiGrass, and soon to be home of Australia’s newest medical cannabis company, NimbinCann.

NimbinCann plans to disrupt Australia’s medical cannabis industry, which is currently riddled with issues. The end cost for consumers is too high, the quality of the products has been questioned by the TGA itself, and major stock shortages have been creating havoc for patients around the country.

Despite all that, medical cannabis in Australia and the rest of the world is growing, faster than anyone thought.

SAS-B approvals by the TGA reached an all-time high of 9,965 in May 2021 – a 141 percent increase on May 2020, and a 39 percent increase in the five months to May 2021 compared to the previous period. A longer-term view projects Australia’s medical cannabis market to be valued at AUD $620 million by 2024. That number more than doubles if recreational cannabis is also legalised.

Local

NimbinCann is on a mission to produce pharmaceutical grade medical cannabis grown in Australian soil and beyond, for both local and global patients. Nimbin itself will house one of the company’s cultivation facility, with a 60 acre plot in development to grow the cannabis.

Multiple types of cannabis will be grown in subdivided areas:

  • 2,000 square metres (sqm) of indoor high-quality GMP-grade Medical Cannabis cultivation area
  • 5,000 sqm indoor greenhouse area
  • 10,000 sqm additional greenhouse area
  • 10,000 sqm for outdoor cultivation area

NimbinCann won’t only be cultivating locally, they’ll also be dispensing it. Byron Bay, Sydney, Surfers Paradise, Brisbane, Melbourne, and of course Nimbin, will all play home to patient-focused dispensaries providing TGA-approved CBD products without prescriptions.

A partnership with Australian-local CannaPacific has also been struck. The deal gives NimbinCann an initial boost, allowing them to use CannaPacific’s licenses, growing facility, and expertise, to start growing and producing their own cannabis strains sooner rather than later.

International

Although born and bred in Australia, NimbinCann will also operate a second site in Thailand – the lone country in Southeast Asia embracing medical cannabis.

Thailand was chosen not only for its rapid law reforms, but as Managing Director Richard Duce explains, “it has what many call ‘The Goldilocks Conditions’ or the perfect growing conditions for medical cannabis”.

Several key strategic partnerships have already been signed with Thai-based Green Pharma Botanical, Newland Technology, and others. These agreements will grant NimbinCann access to an elite group of cannabis farmers and to one of Thailand’s leading cultivators and retailers of cannabis-infused products.

The Thailand facility aims to produce ~300kg of CBD oil within 7 months of launch, harvesting more than 10,000 plants every month, going on to export the medicines to Australia and beyond.

NimbinCann Newfound Technology reach an agreement 2
NimbinCann & Newland Technology reach an agreement

Both the local and Thailand facilities will be run as fully integrated businesses. Research and development, cultivation and production, manufacturing and packaging, and wholesaling and retailing will all be maintained in-house. This helps ensure the highest quality of medicines for patients.

Not only will quality be improved, but prices will drop dramatically. Pharmaceutical grade medical cannabis and hemp in Thailand has a production cost of around $0.06 per gram of dried flower. In western countries like Australia and Canada, it costs between $1 and $2 per gram – making it more than 94% cheaper to produce the medicine in Thailand.

Team

Directors leading the company include Richard Duce, David Evans, and Chris Waldron.

Richard Duce

Richard Duce has decades of experience in the development industry and has spent more than 20 years studying the cannabis industry and its trends. He obtained his first medical cannabis license in the US in 2009.

David Evans

David Evans has founded and listed multiple companies on the ASX including Medical Cannabis Ltd – now part of Cann Global Limited (ASX: CGB). Evans is also a co-founder and major shareholder of Cann Global Thailand Pty Ltd, Cann Global Asia Pty Ltd, and Biorefine Pty Ltd.

Chris Waldron

Chris Waldron has extensive experience in the IT industry including high level positions at the Australian Government Department of Treasury. He is currently the Operations Manager at Cann Global Asia and Cann Global Thailand.

The directors are joined by several other industry professionals on the advisory board including, but not limited to:

  • David Heilpern – Former Lismore Local Court Magistrate Judge and an expert in cannabis law
  • Andrew Kavasilas – Co-founder of Medical Cannabis Ltd and Vitahemp Ltd, and an expert in commercial cannabis cultivation
  • Michael Balderstone – President of the Nimbin HEMP Embassy and one of the most well-known cannabis activists in Australia
  • Diana Roberts – President of the Nimbin Chamber of Commerce and Nimbin Community Centre
  • David Hyett – owner of the renowned Nimbin Bush Café, local businessman, and cannabis industry promoter and enthusiast

The diverse range of expertise that the team brings together supports Managing Director Richard Duce’s beliefs, that the company is poised to be in a prime position to take on the current cannabis landscape in Australia, and the international markets.

NimbinCann plans to be the connoisseur of medical cannabis flower and organic cannabis flowers. Many of the large overseas companies are setting up large industrial scale factories to grow medical cannabis on a mass scale. At NimbinCann we will be going for quality over quantity…that will set up apart from our competition.

Adding on that they aim to be more than just a producer of cannabis medicines.

NimbinCann aims to build a lasting brand and brand loyalty from day one. Quality is king, consistency is queen, and culture is our ace.

Although medical cannabis was federally legalised back in 2016, the industry has taken quite some time to catch on and hasn’t been without its many flaws along the way.

As more and more international companies eye off Australia to export their cannabis medicines, it’s about time a local player brings the priority back to Australian patients.

For more information you can visit NimbinCann’s website.

Tags: Business
Share81Tweet51
Mike Frigger

Mike Frigger

Mike is one of the lead editors at Cannaus. He's an advocate for legalising cannabis and covers much of the cannabis journey in Australia.

Related Posts

Cannabis leaf with seeds
National

WA government classifies a cannabis seed the same as a fully-grown plant

January 13, 2022
Small cannabis plant growing in a pot
National

New Zealand-based cannabis producer Greenfern reaches partnership agreement with Cannvalate

January 13, 2022
Cannabis medicine
National

Study shows the majority of women using medical cannabis for endometriosis obtain it illegally

January 11, 2022
Green cannabis leaf on wood
National

Cannim set to become major name in adult-use cannabis market through strategic merger

December 27, 2021
Cannabis oil with bud
National

Elixinol Wellness (ASX: EXL) signs deal with major British cannabis company

December 27, 2021
Penalty
National

TGA fines St Francis Pharmacy nearly $40k for advertising medicinal cannabis

December 23, 2021
Subscribe
Notify of
guest
guest
3 Comments
Inline Feedbacks
View all comments
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address
  • Home
  • Contact
  • Privacy Policy

Disclaimer
Cannaus does not recommend that anyone uses cannabis for medical or adult use purposes unless consulted by a medical professional. Cannabis is a drug and may have negative side effects. Please consult with your doctor to find out if cannabis is right for you.

  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address

Thanks, I’m not interested

wpDiscuz